Essentially 300 international authorities present the New Edition of the standard reference for cardiovascular drug therapy. Those available cardiovascular drugs and those on the horizon are discussed - making Cardiovascular Drug Therapy, 2/e the resource cardiologists will turn to first to find out what's available and most effective. The second edition has been completely revised and updated. There are 182 chapters, of which 55 are new. Expands the section on antithrombotic therapy to include several low molecular heparin derivatives. Features an expert Editorial Board that rigorously reviews coverage to ensure state-of-the-art guidance.